Heart-Cardiovascular Surgery

With Mount Sinai Heart at Mount Sinai Morningside, you get the personal attention of a mid-sized hospital, together with expert care by world-renowned physicians and surgeons. Led by John D. Puskas, MD, a global leader in the treatment of coronary artery disease, Mount Sinai Morningside and Mount Sinai West are ranked among the top 20 in the nation for Cardiology & Heart Surgery by U.S. News & World Report® for 2023-24.

A Leader in the Treatment of Coronary Artery Disease

Coronary artery disease is the leading cause of death in the United States for both men and women. Dr. Puskas has pioneered a broad range of minimally invasive surgical techniques and is known internationally for his expertise in “off-pump” coronary bypass surgery—which avoids using the heart-lung machine and minimizes the risk of complications such as stroke, renal failure, and other adverse outcomes, including the need for blood transfusion.

While coronary artery bypass grafting (CABG) is not new, Dr. Puskas’ advanced techniques for off-pump coronary artery bypass grafting (OPCAB) have been proven to offer superior outcomes. Almost all centers in the US clamp the aorta during CABG surgery and perform CABG operations with a single artery graft and several vein grafts. But the use of arterial grafts instead of veins can make bypass grafts last decades longer. And procedures that avoid the manipulation of the aorta (anaortic OPCAB), dramatically reduce the risk of stroke and other negative outcomes.

Mount Sinai Morningside recently received the coveted three-star rating from the Society of Thoracic Surgeons (STS) for its patient care and outcomes in isolated coronary artery bypass grafting (CABG) procedures. The three-star rating, which denotes the highest category of quality, places Mount Sinai Morningside among the elite hospitals for heart bypass surgery in the United States and Canada.

Many patients have received numerous coronary artery stents before being referred for CABG surgery. Sometimes, so many stents have been inserted that the patient’s coronary arteries may have a “full metal jacket”, prohibiting CABG surgery in almost all cardiac surgery centers. Dr Puskas and his colleagues have advanced a technique known as “stentectomy/endarterectomy”, which involves removing previous stents and performing a coronary bypass grafting procedure for patients who are told that their “full metal jacket” cannot be treated.

Specialists for Every Heart Condition

Our specialists treat the full spectrum of heart conditions, including valve disorders, aortic conditions, atrial fibrillation, and pulmonary embolisms. In addition to common heart conditions, we are one of the few centers in the nation to also specialize in the treatment of hypertrophic obstructive cardiomyopathy, a hereditary condition in which the heart’s muscle becomes abnormally large, contributing to shortness of breath and fatigue.

Why Mount Sinai Morningside

Our Heart team approach means that you have a group of highly trained specialists to guide every decision about your care. If you have other underlying conditions, such as diabetes, we will draw in other specialists, as needed. Mount Sinai Morningside’s cardiology and cardiovascular surgery department offers unrivaled, state-of-the-art diagnostics and treatments—and your Heart team will work together to provide personalized treatment in a warm and compassionate environment.

  • Aortic dissection surgery
  • Aortic valve reconstruction
  • Aortic root surgery
  • Bicuspid valve surgery
  • Cardiac surgery, robotic and reoperative
  • Coronary artery bypass grafting (CABG), including total arterial revascularization, off-pump CABG, and total endoscopic coronary artery bypass surgery
  • Left ventricular aneurysm surgery
  • Pacemaker Implantation & Resynchronization Therapy
  • Pulmonary embolectomy
  • Pulmonary artery endarterectomy
  • Transcatheter aortic valve replacement (TAVR)
  • Thoracic aortic surgery
  • Thoracoabdominal aortic surgery
  • Minimally invasive extraction of masses and thrombi from the heart
  • Minimally Invasive Hybrid Atrial Fibrillation Therapy